Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis

Antibiotics are known to cause severe cutaneous adverse reactions, such as the rare acute generalized exanthematous pustulosis (AGEP). Unlike Stevens-Johnson syndrome or toxic epidermal necrolysis, AGEP is rarely life-threatening. Systemic involvement is not typical, and if present usually coincides...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International archives of allergy and immunology 2017-11, Vol.174 (2), p.108-111
Hauptverfasser: Tajmir-Riahi, Azadeh, Wörl, Petra, Harrer, Thomas, Schliep, Stefan, Schuler, Gerold, Simon, Miklos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111
container_issue 2
container_start_page 108
container_title International archives of allergy and immunology
container_volume 174
creator Tajmir-Riahi, Azadeh
Wörl, Petra
Harrer, Thomas
Schliep, Stefan
Schuler, Gerold
Simon, Miklos
description Antibiotics are known to cause severe cutaneous adverse reactions, such as the rare acute generalized exanthematous pustulosis (AGEP). Unlike Stevens-Johnson syndrome or toxic epidermal necrolysis, AGEP is rarely life-threatening. Systemic involvement is not typical, and if present usually coincides with a mild elevation of the hepatic enzymes and a decrease in renal function. Hence, AGEP is known to have a good prognosis and to be life-threatening only in elderly patients or patients with chronic diseases. Herein, we report a case of AGEP in a young healthy male leading to systemic inflammatory response syndrome and to treatment in an intensive care unit after being treated with 5 different antibiotics. Initial symptoms were not indicative for AGEP and the patient's course of disease led promptly to critical cardiorespiratory symptoms and systemic inflammatory response syndrome. We assume that the administration of the 5 different antibiotics resulted in type IV allergy as well as secondary infection with Enterococcus faecium and Staphylococcus aureus, while the underlying periodontitis also contributed to the severity of this case.
doi_str_mv 10.1159/000480700
format Article
fullrecord <record><control><sourceid>gale_karge</sourceid><recordid>TN_cdi_gale_infotracmisc_A637226279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A637226279</galeid><sourcerecordid>A637226279</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-1034bf3437a1a79a16daad8cc097bafcb857169bca596008fa663ed4e084d7903</originalsourceid><addsrcrecordid>eNpt0c2L1DAYBvAgiruuHryLFIQFD13fNG0-jsOwuwoDeljP5W36ZiZr24xJCq5_vZUZRxckh4Twe_LBw9hrDlecN-YDANQaFMATds7rSpQARj1d1sB1WdVCn7EXKd0DLFjL5-ysMiAbYZpzttl4R-XdLhJmmvy0LVb5Ye8tDsUaExXBFSs7ZypuaaKIg_9JfXH9A6e8oxFzmFPxZU55HkLy6SV75nBI9Oo4X7CvN9d364_l5vPtp_VqU9paqlxyEHXnRC0UclQGuewRe23t8uoOne10o7g0ncXGSADtUEpBfU2g614ZEBfs3eHcfQzfZ0q5vQ9znJYrW250oyvBpfirtjhQ6ycXckQ7-mTblRSqqmSlzKKu_qOW0dPobZjI-WX_UeDyn8COcMi7FIY5-zClx_D9AdoYUork2n30I8aHlkP7u7f21Nti3x5_NHcj9Sf5p6gFvDmAbxi3FE_gmP8FDBOYQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1985823163</pqid></control><display><type>article</type><title>Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis</title><source>MEDLINE</source><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Tajmir-Riahi, Azadeh ; Wörl, Petra ; Harrer, Thomas ; Schliep, Stefan ; Schuler, Gerold ; Simon, Miklos</creator><creatorcontrib>Tajmir-Riahi, Azadeh ; Wörl, Petra ; Harrer, Thomas ; Schliep, Stefan ; Schuler, Gerold ; Simon, Miklos</creatorcontrib><description>Antibiotics are known to cause severe cutaneous adverse reactions, such as the rare acute generalized exanthematous pustulosis (AGEP). Unlike Stevens-Johnson syndrome or toxic epidermal necrolysis, AGEP is rarely life-threatening. Systemic involvement is not typical, and if present usually coincides with a mild elevation of the hepatic enzymes and a decrease in renal function. Hence, AGEP is known to have a good prognosis and to be life-threatening only in elderly patients or patients with chronic diseases. Herein, we report a case of AGEP in a young healthy male leading to systemic inflammatory response syndrome and to treatment in an intensive care unit after being treated with 5 different antibiotics. Initial symptoms were not indicative for AGEP and the patient's course of disease led promptly to critical cardiorespiratory symptoms and systemic inflammatory response syndrome. We assume that the administration of the 5 different antibiotics resulted in type IV allergy as well as secondary infection with Enterococcus faecium and Staphylococcus aureus, while the underlying periodontitis also contributed to the severity of this case.</description><identifier>ISSN: 1018-2438</identifier><identifier>EISSN: 1423-0097</identifier><identifier>DOI: 10.1159/000480700</identifier><identifier>PMID: 29065395</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Acute Generalized Exanthematous Pustulosis - diagnosis ; Acute Generalized Exanthematous Pustulosis - pathology ; Adult ; Allergies ; Amoxicillin - adverse effects ; Amoxicillin - immunology ; Amoxicillin - therapeutic use ; Ampicillin - adverse effects ; Ampicillin - immunology ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - immunology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Case reports ; Case studies ; Chronic illnesses ; Ciprofloxacin - adverse effects ; Ciprofloxacin - immunology ; Ciprofloxacin - therapeutic use ; Cutaneous manifestations of general diseases ; Diagnosis ; Drug allergy ; Enterococcus faecium - isolation &amp; purification ; Enzymes ; Geriatrics ; Humans ; Inflammation ; Inflammatory response ; Male ; Medical treatment ; Novel Insights from Clinical Practice ; Older people ; Penicillin G - adverse effects ; Penicillin G - immunology ; Penicillin G - therapeutic use ; Periodontitis ; Periodontitis - drug therapy ; Periodontitis - microbiology ; Pustulosis ; Renal function ; Secondary infection ; Staphylococcal Infections - complications ; Staphylococcus aureus - isolation &amp; purification ; Staphylococcus infections ; Stevens-Johnson syndrome ; Sulbactam - adverse effects ; Sulbactam - immunology ; Sulbactam - therapeutic use ; Systemic inflammatory response syndrome ; Systemic Inflammatory Response Syndrome - pathology ; Toxic epidermal necrolysis</subject><ispartof>International archives of allergy and immunology, 2017-11, Vol.174 (2), p.108-111</ispartof><rights>2017 S. Karger AG, Basel</rights><rights>2017 S. Karger AG, Basel.</rights><rights>COPYRIGHT 2017 S. Karger AG</rights><rights>Copyright S. Karger AG Nov 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-1034bf3437a1a79a16daad8cc097bafcb857169bca596008fa663ed4e084d7903</citedby><cites>FETCH-LOGICAL-c467t-1034bf3437a1a79a16daad8cc097bafcb857169bca596008fa663ed4e084d7903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2422,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29065395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tajmir-Riahi, Azadeh</creatorcontrib><creatorcontrib>Wörl, Petra</creatorcontrib><creatorcontrib>Harrer, Thomas</creatorcontrib><creatorcontrib>Schliep, Stefan</creatorcontrib><creatorcontrib>Schuler, Gerold</creatorcontrib><creatorcontrib>Simon, Miklos</creatorcontrib><title>Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis</title><title>International archives of allergy and immunology</title><addtitle>Int Arch Allergy Immunol</addtitle><description>Antibiotics are known to cause severe cutaneous adverse reactions, such as the rare acute generalized exanthematous pustulosis (AGEP). Unlike Stevens-Johnson syndrome or toxic epidermal necrolysis, AGEP is rarely life-threatening. Systemic involvement is not typical, and if present usually coincides with a mild elevation of the hepatic enzymes and a decrease in renal function. Hence, AGEP is known to have a good prognosis and to be life-threatening only in elderly patients or patients with chronic diseases. Herein, we report a case of AGEP in a young healthy male leading to systemic inflammatory response syndrome and to treatment in an intensive care unit after being treated with 5 different antibiotics. Initial symptoms were not indicative for AGEP and the patient's course of disease led promptly to critical cardiorespiratory symptoms and systemic inflammatory response syndrome. We assume that the administration of the 5 different antibiotics resulted in type IV allergy as well as secondary infection with Enterococcus faecium and Staphylococcus aureus, while the underlying periodontitis also contributed to the severity of this case.</description><subject>Acute Generalized Exanthematous Pustulosis - diagnosis</subject><subject>Acute Generalized Exanthematous Pustulosis - pathology</subject><subject>Adult</subject><subject>Allergies</subject><subject>Amoxicillin - adverse effects</subject><subject>Amoxicillin - immunology</subject><subject>Amoxicillin - therapeutic use</subject><subject>Ampicillin - adverse effects</subject><subject>Ampicillin - immunology</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - immunology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Case reports</subject><subject>Case studies</subject><subject>Chronic illnesses</subject><subject>Ciprofloxacin - adverse effects</subject><subject>Ciprofloxacin - immunology</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Cutaneous manifestations of general diseases</subject><subject>Diagnosis</subject><subject>Drug allergy</subject><subject>Enterococcus faecium - isolation &amp; purification</subject><subject>Enzymes</subject><subject>Geriatrics</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammatory response</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Novel Insights from Clinical Practice</subject><subject>Older people</subject><subject>Penicillin G - adverse effects</subject><subject>Penicillin G - immunology</subject><subject>Penicillin G - therapeutic use</subject><subject>Periodontitis</subject><subject>Periodontitis - drug therapy</subject><subject>Periodontitis - microbiology</subject><subject>Pustulosis</subject><subject>Renal function</subject><subject>Secondary infection</subject><subject>Staphylococcal Infections - complications</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><subject>Staphylococcus infections</subject><subject>Stevens-Johnson syndrome</subject><subject>Sulbactam - adverse effects</subject><subject>Sulbactam - immunology</subject><subject>Sulbactam - therapeutic use</subject><subject>Systemic inflammatory response syndrome</subject><subject>Systemic Inflammatory Response Syndrome - pathology</subject><subject>Toxic epidermal necrolysis</subject><issn>1018-2438</issn><issn>1423-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0c2L1DAYBvAgiruuHryLFIQFD13fNG0-jsOwuwoDeljP5W36ZiZr24xJCq5_vZUZRxckh4Twe_LBw9hrDlecN-YDANQaFMATds7rSpQARj1d1sB1WdVCn7EXKd0DLFjL5-ysMiAbYZpzttl4R-XdLhJmmvy0LVb5Ye8tDsUaExXBFSs7ZypuaaKIg_9JfXH9A6e8oxFzmFPxZU55HkLy6SV75nBI9Oo4X7CvN9d364_l5vPtp_VqU9paqlxyEHXnRC0UclQGuewRe23t8uoOne10o7g0ncXGSADtUEpBfU2g614ZEBfs3eHcfQzfZ0q5vQ9znJYrW250oyvBpfirtjhQ6ycXckQ7-mTblRSqqmSlzKKu_qOW0dPobZjI-WX_UeDyn8COcMi7FIY5-zClx_D9AdoYUork2n30I8aHlkP7u7f21Nti3x5_NHcj9Sf5p6gFvDmAbxi3FE_gmP8FDBOYQQ</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Tajmir-Riahi, Azadeh</creator><creator>Wörl, Petra</creator><creator>Harrer, Thomas</creator><creator>Schliep, Stefan</creator><creator>Schuler, Gerold</creator><creator>Simon, Miklos</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20171101</creationdate><title>Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis</title><author>Tajmir-Riahi, Azadeh ; Wörl, Petra ; Harrer, Thomas ; Schliep, Stefan ; Schuler, Gerold ; Simon, Miklos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-1034bf3437a1a79a16daad8cc097bafcb857169bca596008fa663ed4e084d7903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute Generalized Exanthematous Pustulosis - diagnosis</topic><topic>Acute Generalized Exanthematous Pustulosis - pathology</topic><topic>Adult</topic><topic>Allergies</topic><topic>Amoxicillin - adverse effects</topic><topic>Amoxicillin - immunology</topic><topic>Amoxicillin - therapeutic use</topic><topic>Ampicillin - adverse effects</topic><topic>Ampicillin - immunology</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - immunology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Case reports</topic><topic>Case studies</topic><topic>Chronic illnesses</topic><topic>Ciprofloxacin - adverse effects</topic><topic>Ciprofloxacin - immunology</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Cutaneous manifestations of general diseases</topic><topic>Diagnosis</topic><topic>Drug allergy</topic><topic>Enterococcus faecium - isolation &amp; purification</topic><topic>Enzymes</topic><topic>Geriatrics</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammatory response</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Novel Insights from Clinical Practice</topic><topic>Older people</topic><topic>Penicillin G - adverse effects</topic><topic>Penicillin G - immunology</topic><topic>Penicillin G - therapeutic use</topic><topic>Periodontitis</topic><topic>Periodontitis - drug therapy</topic><topic>Periodontitis - microbiology</topic><topic>Pustulosis</topic><topic>Renal function</topic><topic>Secondary infection</topic><topic>Staphylococcal Infections - complications</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><topic>Staphylococcus infections</topic><topic>Stevens-Johnson syndrome</topic><topic>Sulbactam - adverse effects</topic><topic>Sulbactam - immunology</topic><topic>Sulbactam - therapeutic use</topic><topic>Systemic inflammatory response syndrome</topic><topic>Systemic Inflammatory Response Syndrome - pathology</topic><topic>Toxic epidermal necrolysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tajmir-Riahi, Azadeh</creatorcontrib><creatorcontrib>Wörl, Petra</creatorcontrib><creatorcontrib>Harrer, Thomas</creatorcontrib><creatorcontrib>Schliep, Stefan</creatorcontrib><creatorcontrib>Schuler, Gerold</creatorcontrib><creatorcontrib>Simon, Miklos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>International archives of allergy and immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tajmir-Riahi, Azadeh</au><au>Wörl, Petra</au><au>Harrer, Thomas</au><au>Schliep, Stefan</au><au>Schuler, Gerold</au><au>Simon, Miklos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis</atitle><jtitle>International archives of allergy and immunology</jtitle><addtitle>Int Arch Allergy Immunol</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>174</volume><issue>2</issue><spage>108</spage><epage>111</epage><pages>108-111</pages><issn>1018-2438</issn><eissn>1423-0097</eissn><abstract>Antibiotics are known to cause severe cutaneous adverse reactions, such as the rare acute generalized exanthematous pustulosis (AGEP). Unlike Stevens-Johnson syndrome or toxic epidermal necrolysis, AGEP is rarely life-threatening. Systemic involvement is not typical, and if present usually coincides with a mild elevation of the hepatic enzymes and a decrease in renal function. Hence, AGEP is known to have a good prognosis and to be life-threatening only in elderly patients or patients with chronic diseases. Herein, we report a case of AGEP in a young healthy male leading to systemic inflammatory response syndrome and to treatment in an intensive care unit after being treated with 5 different antibiotics. Initial symptoms were not indicative for AGEP and the patient's course of disease led promptly to critical cardiorespiratory symptoms and systemic inflammatory response syndrome. We assume that the administration of the 5 different antibiotics resulted in type IV allergy as well as secondary infection with Enterococcus faecium and Staphylococcus aureus, while the underlying periodontitis also contributed to the severity of this case.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>29065395</pmid><doi>10.1159/000480700</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1018-2438
ispartof International archives of allergy and immunology, 2017-11, Vol.174 (2), p.108-111
issn 1018-2438
1423-0097
language eng
recordid cdi_gale_infotracmisc_A637226279
source MEDLINE; Karger Journals Complete; Alma/SFX Local Collection
subjects Acute Generalized Exanthematous Pustulosis - diagnosis
Acute Generalized Exanthematous Pustulosis - pathology
Adult
Allergies
Amoxicillin - adverse effects
Amoxicillin - immunology
Amoxicillin - therapeutic use
Ampicillin - adverse effects
Ampicillin - immunology
Ampicillin - therapeutic use
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - immunology
Anti-Bacterial Agents - therapeutic use
Antibiotics
Case reports
Case studies
Chronic illnesses
Ciprofloxacin - adverse effects
Ciprofloxacin - immunology
Ciprofloxacin - therapeutic use
Cutaneous manifestations of general diseases
Diagnosis
Drug allergy
Enterococcus faecium - isolation & purification
Enzymes
Geriatrics
Humans
Inflammation
Inflammatory response
Male
Medical treatment
Novel Insights from Clinical Practice
Older people
Penicillin G - adverse effects
Penicillin G - immunology
Penicillin G - therapeutic use
Periodontitis
Periodontitis - drug therapy
Periodontitis - microbiology
Pustulosis
Renal function
Secondary infection
Staphylococcal Infections - complications
Staphylococcus aureus - isolation & purification
Staphylococcus infections
Stevens-Johnson syndrome
Sulbactam - adverse effects
Sulbactam - immunology
Sulbactam - therapeutic use
Systemic inflammatory response syndrome
Systemic Inflammatory Response Syndrome - pathology
Toxic epidermal necrolysis
title Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A23%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Life-Threatening%20Atypical%20Case%20of%20Acute%20Generalized%20Exanthematous%20Pustulosis&rft.jtitle=International%20archives%20of%20allergy%20and%20immunology&rft.au=Tajmir-Riahi,%20Azadeh&rft.date=2017-11-01&rft.volume=174&rft.issue=2&rft.spage=108&rft.epage=111&rft.pages=108-111&rft.issn=1018-2438&rft.eissn=1423-0097&rft_id=info:doi/10.1159/000480700&rft_dat=%3Cgale_karge%3EA637226279%3C/gale_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1985823163&rft_id=info:pmid/29065395&rft_galeid=A637226279&rfr_iscdi=true